Elsevier Announces the Appointment of Mirit Eldor to Managing Director of Life Sciences Solutions
London | January 10, 2024
Elsevier, a global leader in information and analytics, announced today the appointment of Mirit Eldor as Managing Director, Life Sciences Solutions. Elsevier’s Life Sciences Solutions business serves pharmaceutical, biotech and life sciences companies around the world with trusted, data-led analytical insights that help research and development teams innovate effectively and efficiently using curated and validated scientific information.
Ms. Eldor takes on the leadership of the Life Sciences Solutions business after almost a decade at Elsevier. In her most recent role, she led Strategy for Elsevier globally and served on the Executive Leadership Team. Prior to this role, she was Senior Vice President of Strategy for the Health & Commercial segments, a role in which she worked closely with the Life Sciences business on strategy development and market execution.
On her new role, Ms. Eldor said, “It’s an honour to lead the Life Sciences Solutions business, which brings together data, analytics and advanced technologies in novel ways. I am excited to partner with our customers across the Life Sciences industry as they make new scientific discoveries, develop targeted medicines and ensure compliance and drug safety with validated scientific content and data optimised through advanced AI-enabled tools.”
Before joining Elsevier, Ms. Eldor worked for Thomson Reuters in various strategy roles across its business sectors, including legal, intellectual property (IP) solutions, and life sciences. Earlier in her career, she was a strategy consultant with McKinsey & Company and an IP lawyer, specializing in IP licensing and protection. Ms. Eldor holds an MBA from Imperial College, London, and an LL.B. (Magna cum laude) from Tel-Aviv University.
In addition to her new role, Ms. Eldor will continue to serve as Secretary of Elsevier’s Inclusion and Diversity External Advisory Board.
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, academic leaders, funders, R&D-intensive corporations, doctors, and nurses.
Elsevier employs 9,000 people worldwide, including over 2,500 technologists. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, medical education, and nursing education. Researchers and healthcare professionals rely on over 2,900 digitized journals, including The Lancet(opens in new tab/window) and Cell(opens in new tab/window); 46,000+ eBook titles; and iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation(opens in new tab/window) and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Elsevier is part of RELX(opens in new tab/window), a global provider of information-based analytics and decision tools for professional and business customers.